MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0051069

Медицинская библиотека · PloS one · 2012

Hsp40 gene therapy exerts therapeutic effects on polyglutamine disease mice via a non-cell autonomous mechanism.

Popiel H Akiko, Takeuchi Toshihide, Fujita Hiromi, Yamamoto Kazuhiro, Ito Chiyomi, Yamane Hiroshi, Muramatsu Shin-ichi, Toda Tatsushi, Wada Keiji, Nagai Yoshitaka

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

The polyglutamine (polyQ) diseases such as Huntington's disease (HD), are neurodegenerative diseases caused by proteins with an expanded polyQ stretch, which misfold and aggregate, and eventually accumulate as inclusion bodies within neurons. Molecules that inhibit polyQ protein misfolding/aggregation, such as Polyglutamine Binding Peptide 1 (QBP1) and molecular chaperones, have been shown to exert therapeutic effects in vivo by crossing of transgenic animals. Towards developing a therapy using these aggregation inhibitors, we here investigated the effect of viral vector-mediated gene therapy using QBP1 and molecular chaperones on polyQ disease model mice. We found that injection of adeno-associated virus type 5 (AAV5) expressing QBP1 or Hsp40 into the striatum both dramatically suppresses inclusion body formation in the HD mouse R6/2. AAV5-Hsp40 injection also ameliorated the motor impairment and extended the lifespan of R6/2 mice. Unexpectedly, we found even in virus non-infected cells that AAV5-Hsp40 appreciably suppresses inclusion body formation, suggesting a non-cell autonomous therapeutic effect. We further show that Hsp40 inhibits secretion of the polyQ protein from cultured cells, implying that it inhibits the recently suggested cell-cell transmission of the polyQ protein. Our results demonstrate for the first time the therapeutic effect of Hsp40 gene therapy on the neurological phenotypes of polyQ disease mice.

Для цитирования: Popiel H Akiko, Takeuchi Toshihide, Fujita Hiromi, Yamamoto Kazuhiro, Ito Chiyomi, Yamane Hiroshi, Muramatsu Shin-ichi, Toda Tatsushi, Wada Keiji, Nagai Yoshitaka. Hsp40 gene therapy exerts therapeutic effects on polyglutamine disease mice via a non-cell autonomous mechanism.. PloS one. 2012. DOI: 10.1371/journal.pone.0051069.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.